Q3 2012 · 10-Q
Revenue$96.41M$96.41M +689.1% vs Q3 2011+560.2% vs Q2 2012
Net Income$47.64M$47.64M N/M vs Q3 2011no prior Q2 2012 on file
EPS Diluted$0.42$0.42 N/M vs Q3 2011N/M vs Q2 2012
Operating Income$47,608,000N/M
Operating Cash Flowderived$38,995,000N/M
Free Cash Flowderived$35,437,000N/M
Margins · derived
Operating margin49.4%+226.3 pt vs Q3 2011
Net margin49.4%+218.3 pt vs Q3 2011
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|
| Revenue | $96.41M | $12.22M | $9.06M |
| Net Income | $47.64M | -$20.63M | -$6.75M |
| EPS Diluted | $0.42 | -$0.21 | -$0.08 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ironwood Pharmaceuticals Inc · CIK 1446847 · Engraved from SEC EDGAR